Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Tyson Garfield

Concepts (27)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
4-Aminopyridine
1
2025
30
0.230
Why?
Potassium Channel Blockers
1
2025
47
0.230
Why?
Potassium Channels, Voltage-Gated
1
2025
54
0.220
Why?
Vasodilation
2
2025
519
0.220
Why?
Hyperthermia, Induced
1
2025
119
0.200
Why?
Hyperemia
1
2023
49
0.190
Why?
Endothelium, Vascular
1
2025
952
0.140
Why?
Blood Pressure
1
2025
1765
0.130
Why?
Muscle, Skeletal
2
2025
1818
0.130
Why?
Hypertension
1
2025
1272
0.120
Why?
Vasodilator Agents
2
2025
326
0.090
Why?
Methacholine Chloride
1
2025
50
0.060
Why?
Nitroprusside
1
2025
70
0.060
Why?
Blood Pressure Monitoring, Ambulatory
1
2025
69
0.050
Why?
Femoral Artery
1
2025
183
0.050
Why?
Prostaglandins
1
2023
94
0.050
Why?
Ibuprofen
1
2023
87
0.050
Why?
Cyclooxygenase 2
1
2023
166
0.050
Why?
Hot Temperature
1
2025
396
0.040
Why?
Regional Blood Flow
1
2023
507
0.040
Why?
Female
3
2025
79499
0.020
Why?
Young Adult
1
2025
14330
0.020
Why?
Male
2
2025
73396
0.020
Why?
Humans
3
2025
146342
0.020
Why?
Aged
1
2025
26432
0.010
Why?
Middle Aged
1
2025
36619
0.010
Why?
Adult
1
2025
41087
0.010
Why?
Garfield's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)